Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol for postpartum hemorrhage prevention
NCT04044287Phase 3Unknown
- Sponsor
- The University of the West Indies
- Start
- Jan 2013
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of misoprostol in postpartum hemorrhage (PPH), sponsored by The University of the West Indies. Primary endpoint: Volume of blood loss at the time of delivery at 24 hours. Status: unknown.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04044287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04044287.